Correspondence 0001829126-24-000228 from Aeries Technology, Inc. (AERT, AERTW) (CIK 0001853044) (AERT)
Aeries Technology, Inc. (AERT, AERTW) (CIK 0001853044)
Date: Jan. 16, 2024 · CIK: 0001853044 · Accession: 0001829126-24-000228
AI Filing Summary & Sentiment
File numbers found in text: 333-276173
Referenced dates: January 4, 2024
Show Raw Text
CORRESP
1
filename1.htm
Aeries Technology, Inc.
60 Paya Lebar
Road, #08-13
Paya Lebar Square
Singapore 409051
January 16, 2024
VIA EDGAR
Attention:
Rebekah Reed
Mara Ransom
United States Securities and Exchange Commission
Division of Corporation Finance
Office of Trade & Services
100 F Street, NE
Washington, D.C. 20549
Re:
Aeries Technology, Inc.
Registration Statement on Form S-1
Filed December 20, 2023
File No. 333-276173
Ladies and Gentlemen:
This letter sets forth the response of Aeries Technology, Inc. (the “Company”) to the comments of the staff of the Division of Corporate Finance (the “Staff”) of the Securities and Exchange Commission set forth in your letter dated January 4, 2024, with respect to the above referenced Registration Statement on Form S-1. Concurrently with the submission of this letter, the Company is filing Amendment No. 1 to the Registration Statement on Form S-1 (the “Revised Registration Statement”). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Registration Statement.
Set forth below is the Company’s response to the Staff’s comments. For the Staff’s convenience, we have incorporated your comments into this response letter in italics.
Registration Statement on Form S-1, Filed December 20, 2023
Cover Page
1.
Staff’s comment: For each of the securities being registered for resale, disclose the price or other consideration
that the selling securityholders paid for such securities. In this regard, we note
that the price or consideration is specified for many but not all of the securities.
For example, the price or consideration given for the 3,711,667 Class A ordinary shares
issued to private placement investors pursuant to subscription agreements dated on
and around November 5, 2023 and November 6, 2023, as well as the 5,638,530 Class A ordinary shares issued to Innovo Consultancy DMCC, is not disclosed.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on the cover page of the Revised Registration Statement accordingly.
2.
Staff’s comment: Where you provide the market price of your Class A ordinary shares, disclose the exercise
price of the warrants. As the warrants appear to be out the money, please also disclose
the likelihood that warrant holders will not exercise their warrants. Provide similar
disclosure in the prospectus summary, risk factors, MD&A, and use of proceeds sections,
and disclose that cash proceeds associated with the exercises of the warrants are
dependent upon the share price. As applicable, describe the impact on your liquidity and update the discussion of the ability of your company to fund
your operations on a prospective basis with your current cash on hand.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on the cover page and pages 14, 37, 39 and 67 of the Revised Registration Statement accordingly.
3.
Staff’s comment: We note the significant number of redemptions of your Class A ordinary shares in connection
with your business combination and that the shares being registered for resale will constitute
a significant percentage of your public float. Please disclose the percentage of outstanding
shares being offered for resale pursuant to this registration statement, both based
on your current outstanding share figure and your outstanding share figure assuming
the issuance of all 52,929,181 Class A ordinary shares offered pursuant to this registration
statement. Additionally, the shares being registered for resale seem to have been purchased by the selling securityholders for prices considerably below the
current market price of the Class A ordinary shares. Highlight the significant negative
impact that sales of shares on this registration statement could have on the public
trading price of the Class A ordinary shares.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on the cover page and pages 32 and 33 of the Revised Registration Statement accordingly.
Risk Factors, page 15
4.
Staff’s comment: Include an additional risk factor highlighting the negative pressure potential sales
of shares pursuant to this registration statement could have on the public trading
price of the Class A ordinary shares. To illustrate this risk, disclose the purchase
prices of the Class A ordinary shares being registered for resale and the percentage
that these shares represent of the total number of shares outstanding, both based
on your current outstanding share figure and your outstanding share figure assuming
the issuance of all 52,929,181 Class A ordinary shares offered pursuant to this registration
statement. Also disclose that even though the current trading price is significantly
below the SPAC IPO price, private investors have an incentive to sell because they
will still profit on sales because the price at which they purchased their shares is lower than the price paid by public
investors.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on pages 32 and 33 of the Revised Registration Statement accordingly.
2
Aeries’ Management Discussion and Analysis of Financial Condition and Results of Operations, page 54
5.
Staff’s comment: We note that projected revenues for the year ending December 31, 2023 were $78.9 million, as set forth in the unaudited prospective financial information
prepared by Aeries’ management and provided to the Board of Directors of the SPAC and its financial advisors
in connection with the evaluation of the business combination. We also note that your
actual revenues for the six months ended September 30, 2023 were approximately $33.9 million. Because your projected revenues were based
upon the year ending December 31, 2023 rather than a fiscal year ending March 31, 2024, please confirm your aggregate revenues for the first nine months of calendar
year 2023. If this figure indicates that you will miss the $78.9 million revenue projection,
as appears to potentially be the case, please update your disclosure regarding liquidity
and capital resources, and elsewhere, to provide updated information about the company’s financial position and further risks to the business operations and liquidity in light of these circumstances.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on page 67 of the Revised Registration Statement accordingly.
Liquidity and Capital Resources, page 62
6.
Staff’s comment: In light of the significant number of redemptions, consideration paid pursuant to
Non-Redemption Agreements and other uses of funds held in the SPAC’s trust account, and the unlikelihood that the company will receive significant proceeds
from exercises of the warrants because of the disparity between the exercise price
of the warrants and the current trading price of the Class A ordinary shares, expand
your discussion of capital resources to address any changes in the company’s liquidity position since the business combination. If the company is likely to have
to seek additional capital, discuss the effect of this offering on the company’s ability to raise additional capital.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on page 67 of the Revised Registration Statement accordingly.
7.
Staff’s comment: We note your statement that you “may raise additional funds through public or private...equity
financing.” Please expand your discussion here to reflect the fact that this offering
involves the potential sale of a substantial portion of shares for resale and discuss
how such sales could impact the market price of the Class A ordinary shares and, therefore,
the amount of potential proceeds available to you. Your discussion should highlight
the fact that Innovo Consultancy DMCC, a beneficial owner of 36.1% of your outstanding Class A ordinary shares, will be able to sell all of
its shares for so long as this registration statement is available for use.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on page 67 of the Revised Registration Statement accordingly.
3
8.
Staff’s comment: We note that, pursuant to your Forward Purchase Agreements with certain investors,
you will be required to pay the Maturity Consideration (as defined in the Forward
Purchase Agreements) upon settlement of the agreements at the first anniversary of
the closing of the business combination. We also note your disclosure on page 51 that
the related net derivative asset of $32.4 million recorded in your unaudited pro forma
condensed combined balance sheet as of September 30, 2023 is subject to re-measurement and change. Please revise to discuss these agreements
and the risks they may pose to other holders. For example, discuss payment of the
Maturity Consideration and how this may impact the cash you have available for other
purposes and to execute your business strategy.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on pages 34 and 46 of the Revised Registration Statement accordingly.
Item 16. Exhibits and Financial Statement Schedules, page II-3
9.
Staff’s comment: We note that the legal opinion of Walkers (Cayman) LLP filed as Exhibit 5.1 to the registration
statement does not appear to cover all of the securities being registered for resale.
The opinion references the resale of a total of 3,774,335 Class A ordinary shares,
whereas the cover page of the registration statement indicates that the prospectus
relates to the resale of an aggregate of 13,485,870 Class A ordinary shares. Further,
the opinion references “the issuance of up to 361,338 Class A ordinary shares to certain
vendors and third parties in lieu of cash as consideration for expenses incurred in
connection with the business combination,” while the cover page suggests that the
resale, rather than issuance, of these shares is being registered. The legality of
the 9,527,810 warrants being registered for resale also does not appear to be covered by this opinion. Please provide a revised, signed opinion or opinions as to the legality of all securities
being registered.
Response: The Company acknowledges the Staff’s comment and has appended a revised legal opinion of Walkers (Cayman) LLP filed as Exhibit 5.1 and a legal opinion of Kirkland & Ellis LLP filed as Exhibit 5.2 to the Revised Registration Statement accordingly.
General
10.
Staff’s comment: Revise your prospectus to highlight the differences in the current trading price of
the Class A ordinary shares, the prices at which the Sponsor, PIPE investors, and
other selling securityholders acquired their shares and warrants, and the price at
which the public securityholders acquired their shares and warrants. Disclose that
while the Sponsor, PIPE investors, and other selling securityholders may experience
a positive rate of return based on the current trading price, the public securityholders
may not experience a similar rate of return on the securities they purchased due to
differences in the purchase prices and the current trading price. Please also disclose
the potential profit that the various selling securityholders will earn based on the
current trading price. Include appropriate risk factor disclosure on this topic.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on the cover page and pages 32 and 33 of the Revised Registration Statement accordingly.
4
11.
Staff’s comment: Please revise to update your disclosures throughout the filing and address areas that appear
to need updating or that present inconsistencies. Non-exclusive examples of areas where disclosure should be updated are as follows:
●
You refer to “projected financial information” on pages 7 and 18 but we could not
find these projected results.
●
You state on page 33 that shareholders “...may be diluted by the future issuance of
additional Class A ordinary shares...” Please update this disclosure to reflect that
this registration statement is facilitating such dilution by registering the issuance
of additional Class A ordinary shares.
●
Throughout the “Description of the Business Combination” section beginning on page
41, you describe actions connected to the business combination in prospective terms. For example, you state, “...at the Closing, WWAC and AARK will
consummate the Business Combination...” and “...the Company will issue to NewGen Advisors
and Consultants...one Class V ordinary share of the Company...” Please revise this
section in light of the consummation of the business combination.
●
You refer on page 142 to a discussion of certain restrictions upon transfer in the
section entitled “Securities Eligible for Resale - Lock-Up Agreements” however we
could not locate such discussion.
Response: The Company acknowledges the Staff’s comment and has revised the disclosure on pages 7, 18, 36, 44, 45, 46 and 148 of the Revised Registration Statement accordingly.
*****
5
We respectfully request the Staff’s assistance in completing the review of the Registration Statement, as amended, as
soon as possible. Please contact Debbie P. Yee of Kirkland & Ellis LLP at (713) 836-3600 with any questions or further comments regarding the responses to the Staff’s comments.
Sincerely,
AERIES TECHNOLOGY, INC.
By:
/s/ Sudhir Appukuttan Panikassery
Name:
Sudhir Appukuttan Panikassery
Title:
Chief Executive Officer
CC: Debbie P. Yee, Kirkland & Ellis LLP
Lance K. Hancock, Kirkland & Ellis LLP
6